BASF SE
About BASF SE
Categories

-
DE
-
2015On CPHI since
-
5000+Employees
Company types
Meet us at
CPHI Frankfurt 2025
Messe Frankfurt
28 Oct 2025 - 30 Oct 2025
Pharmapack Europe 2026
Paris Expo, Porte de Versailles - Hall 4 | Paris, France
21 Jan 2026 - 22 Jan 2026
Products from BASF SE (5)
-
Product Blocking Group Removal Catalysts
BASF’s Blocking Group Removal catalysts technology was developed in response to the specific needs of the pharmaceutical and fine chemical marketplace.
https://catalysts.basf.com/files/literature-library/122009BF-8470_US_Blocking-Group-Removal_Datasheet.pdf
-
Product Fine Chemical Catalysts Brochure
The cost-effective production of active pharmaceutical ingredients, agrochemicals, nutrition components or flavors and fragrances gains more and more importance in industry. Catalysts play a key role in most reaction steps and their optimum selection and operation ensures the highest process yields and eff... -
Product Biomass Balance - BMBcert™
• 100% substitution of fossil with renewable raw materials in the value chain • Significant reduction of product carbon footprint compared to standard BASF product • Drop-in solution: Identical quality and properties compared to standard BASF product • Availabl... -
Product Chemcycling: Ccycled™
• Recycled feedstocks used • Allocation to products via Mass-Balance -
Product Zero PCF Products
• Cradle-to-gate product carbon footprint (PCF) of zero • PCF of zero achieved through use of renewable raw materials via BASF's biomass balance approach • Use of renewable energy and benefits of BASF’s Verbund • Drop-in solution: Identical quality ...
BASF SE Resources (4)
-
Brochure BASF Pharma Solutions Product Overview
With its expertise in polymer chemistry, R&D-capabilities and its commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels, Skin-Delivery and Biologics. BASF is the leading supplier of select APIs such as ibuprofen and omega-3. -
Brochure Supporting Your COVID-19 Therapy Development
Healthcare and pharmaceutical development are at the forefront of the COVID-19 crisis as we know it. The BASF Pharma Solutions team is actively engaged in supporting the COVID-19 therapy developments of our customers in a comprehensive way. -
Brochure Helping Customers Evaluate their Nitrosamine Risk Level
Nitrosamine Risk Assessments for pharmaceutical excipients are now available for instant download in RegXcellence™️. These statements provide increased transparency to our customers and help to better understand the potential for Nitrosamine formation and presence. -
Video Streamline Compliance with RegXcellence™️ from BASF Pharma Solutions
RegXcellence®️ is available online 24/7 to help customers easily navigate the complex quality and regulatory space. Customers can access a compliance document library, connect with global and regional experts, stay up to date on all documentation and requests, and more.